Zytiga Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

zytiga

janssen-cilag international n.v. - abirateroniasetaatti - prostatiset kasvaimet - endokriinihoito - zytiga on merkitty prednisoni tai prednisoloni:metastasoituneen kastraation kastraatioresistentin eturauhassyövän aikuiset miehet, jotka ovat oireettomia tai lievästi oireileva jälkeen epäonnistuminen androgeenideprivaatiohoito joille kemoterapiaa ei ole vielä kliinisesti indicatedthe metastasoituneen kastraation kestävä eturauhassyövän hoitoon aikuisilla miehillä, joiden tauti on edennyt, tai kun docetaxel perustuu solunsalpaajahoito.

Vyndaqel Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

vyndaqel

pfizer europe ma eeig - tafamidis - amyloidoosi - muut hermoston huumeet - vyndaqel on tarkoitettu kohtelu transthyretin amyloidoosi aikuispotilailla, joilla on 1 vaihe oireenmukaista polyneuropatia lykätä reuna neurologinen heikkeneminen.

Burana 20 mg/ml oraalisuspensio Phần Lan - Tiếng Phần Lan - Fimea (Suomen lääkevirasto)

burana 20 mg/ml oraalisuspensio

orion corporation - ibuprofen - oraalisuspensio - 20 mg/ml - ibuprofeeni

POSIREX HONEY-LEMON 1.2 mg / 0.6 mg imeskelytabletti Phần Lan - Tiếng Phần Lan - Fimea (Suomen lääkevirasto)

posirex honey-lemon 1.2 mg / 0.6 mg imeskelytabletti

orion oyj - amylmetacresolum,2,4-dichlorbenzylalcoholum - imeskelytabletti - 1.2 mg / 0.6 mg - diklooribentsyylialkoholi

POSIREX MINT 1.2 mg / 0.6 mg imeskelytabletti Phần Lan - Tiếng Phần Lan - Fimea (Suomen lääkevirasto)

posirex mint 1.2 mg / 0.6 mg imeskelytabletti

orion oyj - amylmetacresolum,2,4-dichlorbenzylalcoholum - imeskelytabletti - 1.2 mg / 0.6 mg - diklooribentsyylialkoholi

BORTEZOMIB TEVA 3.5 mg injektiokuiva-aine, liuosta varten Phần Lan - Tiếng Phần Lan - Fimea (Suomen lääkevirasto)

bortezomib teva 3.5 mg injektiokuiva-aine, liuosta varten

teva b.v. - bortezomibum - injektiokuiva-aine, liuosta varten - 3.5 mg - bortetsomibi

BORTEZOMIB TEVA 2.5 mg injektiokuiva-aine, liuosta varten Phần Lan - Tiếng Phần Lan - Fimea (Suomen lääkevirasto)

bortezomib teva 2.5 mg injektiokuiva-aine, liuosta varten

teva b.v. - bortezomibum - injektiokuiva-aine, liuosta varten - 2.5 mg - bortetsomibi

BORTEZOMIB EBEWE 3.5 mg injektiokuiva-aine, liuosta varten Phần Lan - Tiếng Phần Lan - Fimea (Suomen lääkevirasto)

bortezomib ebewe 3.5 mg injektiokuiva-aine, liuosta varten

ebewe pharma ges.m.b.h. nfg.kg - bortezomibum - injektiokuiva-aine, liuosta varten - 3.5 mg - bortetsomibi

Abiraterone Accord Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateroniasetaatti - prostatiset kasvaimet - endokriinihoito - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Mylan Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateroniasetaatti - prostatiset kasvaimet - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.